SCHEMBL6509570

SCHEMBL6509570

CCCCCCCCCCC(CCCc1nnn[nH]1)c1nnn[nH]1

nearest known ligand 0.34

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 1/20 0.32
PKM P14618 1/20 0.32
HPGD P15428 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19558131 0.89 LMNA (0.33) ALDH1A1
SCHEMBL18649822 0.89 LMNA (0.33) ALDH1A1
SCHEMBL18551463 0.89 LMNA (0.33) ALDH1A1
SCHEMBL20824834 0.87 OPRM1 (0.32)
SCHEMBL20915188 0.82 NR1I2 (0.36)
SCHEMBL20936526 0.82 NR1I2 (0.36)
SCHEMBL20915223 0.82 NR1I2 (0.36)
SCHEMBL20915422 0.82 NR1I2 (0.36)
SCHEMBL20915291 0.82 NR1I2 (0.36)
SCHEMBL20936419 0.82 NR1I2 (0.36)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2005068418-A1 SULFIDE AND DISULFIDE COMPOUNDS AND COMPOSITIONS FOR CHOLESTEROL MANAGEMENT AND RELATED USES ESPERION THERAPEUTICS, INC. (US) 2005-07-28 WO disclosed